Google sign-in. No card required.
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
The Sr. Director, Commercialization Partnerships and Operations leads the commercialization partnerships and operations team at RevMed headquarters, with direct leadership responsibility for the Director, Commercialization Partnerships and Operations role(s). Reporting to the Vice President, Commercialization Partnerships, this position sets the strategic direction and operating standards for all commercial and distribution partners. The Senior Director owns portfolio-wide standardization, governance design, process mapping and cross-functional alignment, while directing the team’s execution and partnering with regional commercial heads on relationship management and commercial readiness.
As a leader for commercialization partnerships and distributorships, this role serves as a strategic advisor to senior executives on partnership strategy, distribution models, governance, and portfolio performance. The Senior Director aligns RevMed’s internal functional teams (Supply Chain, Regulatory, Quality, Medical Affairs, Finance, and Legal) and external commercial distribution partners around consistent operating processes that support commercial readiness, regulatory/MAA approval, compliant named-patient access programs, and reliable product supply across the commercial partnership portfolio.
Key Performance Indicators (KPIs) & Governance Framework:
-
Consistent KPI Architecture : Set and own a unified commercial and operational KPI framework across all commercial partnerships and distribution partners; establish consistent definitions, reporting standards, and review cadences, and oversee implementation by the Director-level team and regional stakeholders.
-
Governance & Decision-Making: Design and own the governance model across all commercial partnerships and distributorships, including standardized charters, membership, meeting cadences, and decision rights for Joint Steering Committees (JSC), Joint Commercial Committees (JCC), and Joint Operations Committees (JOC), as well as joint pricing decisions. Guide the team’s implementation and ensure alignment with regional commercial heads and functional leaders.
-
Map and standardize end-to-end processes across all commercial partnerships and distributorships, defining accountable owners, cross-functional handoffs, escalation pathways, charter guidelines, voting rights, and decision-making matrices (RevMed vs. Partner/Distributor) across commercial, pricing, regulatory, and supply chain domains. Establish documented playbooks and oversee consistent adoption, with clearly defined regional or contractual exceptions.
-
Commercial & Non-Commercial KPIs: Forecast/order accuracy, market access, medical information metrics, performance to volume targets, order-to-cash cycle times, stockout frequency, inventory buffer levels, and lead-time adherence.
-
Regulatory & Quality KPIs: Variances/amendment submission timelines, adherence to quality and PV agreements.
Quarterly Financial Tracking:
-
Set consistent financial reporting standards with RevMed HQ Finance and Partner Commercial Operations across the portfolio. Oversee the team’s quarterly tracking, reporti